August 10, 2026

Health

Nepal allows late-stage trials for Chinese mRNA vaccine candidate - Xinhua

  Nepal has allowed China's Walvax Biotechnology to conduct phase 3 trials for the company's mRNA COVID-19 vaccine candidate in the country, China's official Xinhua news...

Showing 172-190 of 845 results